Background: The potential use of nucleic acids as therapeutic drugs have triggered the quest for oligonucleotide conjugates with enhanced cellular permeability. To this end, the biophysical aspects of previously reported potential lipid oligodeoxynucleotide conjugates were studied including its membranebinding properties and cellular uptake.
Introduction
The ability of some small nucleic acid-based molecules such as DNA decoys, triple helix forming oligonucleotides, RNA decoys, antisense oligonucleotides, ribozymes, DNAzymes, siRNAs or aptamers to silence specific genes or to inhibit the biological activity of specific proteins has generated great interest for their use as research tools and therapeutic agents [1] [2] [3] . Unfortunately, biological applications of oligonucleotides meet a huge limitation namely cellular accessibility [4] . In fact, phospholipid bilayers represent a strong barrier for the highly negatively charged phosphodiester backbone of the oligonucleotides, leading to an extremely poor penetration across the cell membrane. Nevertheless, simple elimination of the anionic charge does not improve cellular uptake, as evidenced by chemically modified neutral backbone-containing oligonucleotides [5] . Therefore developing an appropriate delivery system in order to achieve their efficient cellular uptake remains an important challenge. In this regard, the use of lipid-based systems has long been considered as a possible method to solve cell permeation problems [6] .
The introduction of both neutral and cationic lipids into oligonucleotides is one of the approaches to improve the delivery of these kinds of biomolecules, thereby favoring interaction with, or insertion into the plasma membrane along with improving their stability compared to unmodified oligonucleotides [7, 8] . To date several lipophilic molecules, including cholesterol, phospholipids, α-tocopherol and alkyl chains, have been conjugated to oligonucleotides in order to obtain better clinically acceptable therapeutic drugs [9] [10] [11] [12] [13] [14] . The main goal of these lipophilic compounds is to improve oligonucleotide delivery and to enhance their cellular uptake via receptor-mediated endocytosis by increasing the membrane permeability without altering the potential properties of the nucleic acid molecule, thereby achieving the desired gene expression inhibition [6, [15] [16] [17] [18] [19] .
Recently, our group reported the synthesis of several lipid oligonucleotide conjugates (LOCs) series containing neutral and cationic lipids at their 3'-and 5'-termini and their evaluation in vitro in RNA interference [20, 21] . We observed that all lipid modifications did not disrupt the RNAi machinery obtaining in some cases promising results in inhibiting gene expression without using a transfection agent. Indeed, the siRNA carrying the C 28 moiety at the 5'-end of the passenger strand showed the best inhibitory effects in the absence of the transfecting agent Oligofectamine [21] . It is well-known that cellular uptake and the intracellular distribution of nucleic acids may depend on both their surface properties and their interactions with the cell membrane. In the present work, we study such interactions induced by LOCs conjugates, specially C 28 moiety containing LOC (Fig. 1 ), using three model membrane systems (i.e., monolayers, giant unilamellar vesicles and supported planar bilayers), and several cell lines. As shown in Fig. 1 , the majority of the lipid modifications at both 3'-and 5'-termini were neutral (Fig. 1 , compounds 4-7) based on SNALP formulations; except for one of them in which the lipid attached into the oligonucleotide at 3'-termini showed a polar group at the end of the lipophilic tail (Fig. 1, compound 3) , mimicking the effect produced by lipoplex complexes.
Materials and methods

General methods and materials
All reactions were carried out under argon positive pressure in anhydrous solvents. Commercially available reagents and anhydrous solvents were used without further purification. Solvents were distilled prior to use and dried using standard methods. Analytical samples were homogeneous as confirmed by thin-layer chromatography (TLC) and yielded spectroscopic results were consistent with the assigned structures. TLC was performed on silica gel (Alugram Sil G/UV).
HPLC conditions
Conditions for semipreparative HPLC: HPLC solutions were Solvent A [5% acetonitrile (ACN) in 100 mM triethylammonium acetate (TEAA), pH 6.5] and Solvent B (70% ACN in 100 mM TEAA, pH 6.5).
Column: PRP-1 (Hamilton) 250 x 10 mm. Flow rate 3 ml/min linear gradient from 15 to 100% in B (DMTon) and 0 to 85% in B (DMToff) was used with UV detection at 260 nm. Conditions for analytical HPLC: HPLC solutions were Solvent A [5% ACN in 100 mM TEAA, pH 6.5] and Solvent B (70% ACN in 100 mM TEAA, pH 6.5). Column: XBridge OST C18 2.5 µm. Flow rate 1 ml/min linear gradient from 0 to 85% in B (DMToff) were used with UV detection at 260 nm. Mass spectra were recorded on a MALDI Voyager DE RP time-of-flight (TOF) spectrometer (Applied Biosystems, Framingham). Two different matrix were used: 2,4,6-trihydroxiacetophenone (10 mg/ml in ACN:H 2 O 1:1 v/v); ammonium citrate (50 mg/ml in H 2 O).
Synthesis of modified oligonucleotide conjugates with lipids at either 5'-or 3'-termini
Oligodeoxynucleotides (ODNs) carrying lipids at the 3′-termini were prepared in a DNA synthesizer (Applied Biosystems 3400) using standard 2-cyanoethyl phosphoramidites and modified controlled-pore glass (CPG) solid supports (Suppl. Scheme S1, compounds CPG-1, CPG-2 and CPG-3). These supports were prepared according literature [20, 21] .
ODNs carrying lipids at the 5′-termini were prepared using the same standard 2-cyanoethyl phosphoramidites and the appropriate lipid phosphoramidites (Suppl. Schemes S1 and S2, compounds Ι Ι Ι Ι and Ι Ι Ι ΙΙ Ι Ι Ι). The syntheses were carried out on CPG supports carrying the 2-(N-[9H-fluoren-9-yl-methoxycarbonyl]-4-aminobutyl)propane-1,3-diol linker (Glen Research) to yield oligonucleotide conjugates carrying an aliphatic amino group at the 3′-end and the lipid moiety at 5'-termini. In both cases, after ammonia deprotection (overnight, 55°C) , the resulting modified oligodeoxynucleotides at both 3'-( Fig. 1 and Table 1 , compounds 3-5) and 5'-termini ( Fig. 1 and Table 1 , compounds 6-7) were purified by HPLC (see conditions below) and conjugates were characterized by mass spectrometry (Table 1) .
Sequence 6 was obtained by using commercially available 3'-amino modifier CPG resin and standard 2-cyanethyl phosphoramidites purifying it according to conditions described below.
ODNs carrying lipids at the 3′-termini and an amine group at 5'-termini were prepared using standard 2-cyanethyl phosphoramidites and modified CPG solid supports (Suppl. Scheme S1, compounds CPG-2
and CPG-3) as described above. The introduction of the amino group at the 5'-end was achieved using the commercially available 5'-amino-modifier-C6-Tfa phosphoramidite (Glen Research) obtaining the corresponding LOC conjugates ( Table 1 , compounds 8 and 9). The amine oligonucleotide conjugates were used without further purification in the next step.
Compounds 1-9 (Table 1) were characterized by MALDI-TOF mass spectrometry and HPLC chromatography (Suppl. Figs. S1-S7 and S15-S16).
Synthesis of modified oligonucleotide conjugates with lipids at either 3'-or 5'-termini carrying Alexa 488 as a fluorescent dye
A solution of the deprotected amine oligonucleotide conjugates described above were passed through a column filled with Dowex 50x2, sodium form to remove the interfering ammonium ions coming from the cleavage step. Conjugates 6, 7, 8 and 9 (Table 1) were dissolved with 50 µL of an aqueous solution of 0.2 M NaHCO 3 (pH 9). Then, 1.1 equiv of Alexa Fluor 488 tetrafluorophenyl ester dissolved in 30 µL DMF was added to the solution and left to react overnight at room temperature. The mixture was concentrated to dryness, and the residue was dissolved in H 2 O (1 ml). The green solutions were purified with Sephadex G-25 (NAP-10 Column), and the corresponding oligonucleotide fractions were analyzed and purified by semi-preparative HPLC. In the preparation of sequences 12 and 13 ( Fig. 1 and Table 1 ) we were not able to separate by HPLC the labeled and unlabelled conjugates (Suppl. Figs. S10 and S11). For this reason the mixtures were used in the study.
Compounds 10-14 (Table 1) were characterized by MALDI-TOF mass spectrometry and HPLC chromatography (Suppl. Figs. S8-S11).
Synthesis of lipid oligonucleotide conjugates carrying Cy5 fluorescent dye at the 5'-end
In order to obtain the corresponding oligonucleotide conjugates with Cy5 fluorescent label attached at 5'-termini, we used the same modified CPG solid supports (Suppl. Scheme S1, compounds CPG-1, CPG-2 and CPG-3). The last coupling was carried out manually, introducing the commercially available Cy5 phosphoramidite (Glen Research) into the corresponding CPG resins. DNA syntheses were carried out using the dmf-dG-CE phosphoramidite (Link Technologies). After deprotection with ammonia solution (6 h at room temperature) and purification by semi-preparative HPLC (see below), the corresponding lipid oligonucleotide conjugates with Cy5 were obtained.
Compounds 15-18 (Table 1) were characterized by MALDI-TOF mass spectrometry and HPLC chromatography (Suppl. Figs. S12-S14 and S17).
All conjugates were lyophilized and dissolved in phosphate-buffered saline (1× PBS) for further experiments with lipid membrane model and cell systems.
Surface tension measurements
The studies were carried out at 22ºC using a µThrough-S equipment (Kibron Inc., Finland) consisting of 2-cm rounded multi-well plate that allowed for 1 ml subphase measurements. 
Giant unilamellar vesicle (GUV) preparation
Sucrose-enclosing GUVs were prepared using the electroformation method as described previously [22] . DOPC/egg sphingomyelin (eSM)/cholesterol (Chol) (2:2:1) stock solutions were prepared to contain 
Supported planar bilayer (SPB) preparation
Planar bilayer preparation on mica substrate was performed using the vesicle adsorption technique [23] . respectively. Image treatment was performed using Leica Application Suite software.
Cell Lines
HeLa ( surface. Additionally, J774A.1 CR3-cell line, which does not express β 2 integrin, was also used in this study.
Cell Culture
Cells were cultured as exponentially growing subconfluent monolayers and maintained in Dulbecco's modified Eagle's medium (DMEM, PAA Laboratories GMBH) supplemented with 10% fetal bovine serum (FBS) (Invitrogen), 4 mM L-Glutamine (Sigma-Aldrich), Mycokill AB (PAA Laboratories GMBH), and penicillin/streptomycin (100 units/ml and 100 µg/ml, respectively) (Invitrogen) in a humidified atmosphere consisting of 5% CO 2 and 95% air. The culture media used for U87.CD4.CXCR4, CHO CR3+ and J774A.1 CR3-cells were also supplemented with 1 µg/ml puromycin and 300 µg/ml Geneticin (G418 sulphate), 150 µg/ml hygromycin B and 500 µg/ml G418, and 1.5 µg/ml puromycin, respectively.
Mycoplasma detection assay
Venor®GeM Mycoplasma Detection Kit was used to discard cell cultures contaminated with Mycoplasma.
Cell cytotoxicity assay
Cells were seeded in 96-well plates (2.5 × 10 3 cells/well) and allowed to attach overnight in appropriate growth medium. The medium was then replaced with 100 µl OptiMEM serum-free medium (Gibco, Invitrogen) in the absence or presence of oligonucleotide conjugates and cells were incubated for 24 h or 48 h at 37ºC. Cell growth was estimated by measuring the rate of reduction of the tetrazolium dye MTS to formazan, as previously described [24, 25] . The absorbance of the medium without cells was subtracted from all absorbance values and the control values were considered as 100% of cell viability. Relative cell viability of individual samples was calculated by normalizing their absorbance to that of the corresponding control sample.
Cellular binding/uptake studies by flow cytometry
Cy5-or Alexa 488-labelled ODN was mixed with Transfectin cationic lipid reagent (BIO-RAD), forming ODN-lipoplexes in order to compare conjugation and complexation patterns. Lipoplex formation and incubation parameters (4 h at 37ºC) were set depending on the maximum transfection yield described for Transfectin complexes, following manufacturer's instructions. Cells were seeded at 1.25 × 10 5 cells/well in 24-well plates and incubated overnight in appropriate growth medium. Then cells were incubated in the presence of Cy5-or Alexa 488-labelled LOCs, ODN and ODN-lipoplexes at 37°C for 4 h. All these experiments were performed using OptiMEM because the transfection efficiency of several standard transfection reagents is reduced in the presence of serum [26] [27] [28] [29] [30] . After incubation, cells were completely dissociated in 0.5% Trypsin-EDTA (Invitrogen). Trypsin treated cells were washed by centrifugation at 520 × g for 10 min and then resuspended into ice-cold 1× PBS, followed by a flow cytometry analysis (FACSCalibur, Beckton Dickinson) analyzing 10,000 cells per sample. The fluorescence of Alexa 488-labelled oligonucleotides remaining at the cellular surface was also quenched with 0.2% Trypan Blue (final concentration) (Sigma-Aldrich), and subsequently, the fluorescence corresponding to the internalized oligonucleotides was measured. Alexa 488 fluorescence was measured using an air-cooled 488 nm argon-ion laser, collecting emission signals by FL1 detector. In the case of Cy5, an air-cooled 633 helium-neon ion laser was used and Cy5 emission was collected by FL4 detector. GMFI (Geometric Mean Fluorescence Intensity) data of histograms were used for analysis using WinMDI 2.9 and Cell Quest (BD Biosciences) softwares. For determining the role of CR3 receptor in LOC uptake, these assays were also performed in the presence of fibrinogen, a natural ligand of β 2 integrin. 
Cellular localization assays by confocal microscopy
Cell-surface CR3 receptor staining assay by flow cytometry
Cell-surface CR3 expression was determined by using anti-CD11b FITC conjugated antibody 
Statistical analysis
All measurements were performed at least 3 times, and results are presented as mean ± s.d. Levels of significance were determined by a two-tailed Student's t-test, and a confidence level of greater than 95% (p<0.05) was used to establish statistical significance.
Results and discussion
Synthesis of LOCs
LOCs are a class of bioconjugates that are currently having a great attention from a therapeutic point of view, in particular in antisense and RNA interference therapies due to their unique physicochemical and biological properties. The introduction of lipid units into oligonucleotides at both 3'-and 5'-termini was performed as previously described [20, 21] . anti-HIV-1 activity [31] . Modified CPG solid supports (Suppl. Scheme S1, compounds CPG-1, CPG-2 and CPG-3) were used for the preparation of the corresponding conjugates (Table 1, introduced an amino group at the 3'-end for labeling purposes using standard commercial solid supports.
The introduction of the lipid units was performed using the appropriate lipid phosphoramidites (Suppl.
Schemes S1 and S2, compounds Ι Ι Ι Ι and Ι Ι Ι ΙΙ Ι Ι Ι) according the literature [32] . The corresponding conjugates 6 and 7 were obtained in good yields (Fig. 1) . For comparative purposes the unmodified oligonucleotide sequence carrying the amine modifier at 3'-termini was prepared. All LOC conjugates were successfully characterized by HPLC and MALDI-TOF spectrometry ( Table 1 ). The calculated masses were in good agreement with the measured values ( Table 1) .
Synthesis of fluorescence LOCs modified with Alexa Fluor 488 or Cy5 dyes
In order to carry out the membrane binding studies and the cellular uptake experiments, two different dyes were introduced into the ODN sequences at either 3' or 5'-termini. Alexa Fluor 488 (Life Technologies) was introduced into the LOC conjugates (Table 1 , compounds 6 and 7) along with the control oligonucleotide 2 (Table 1) , taking advantage of the free amine moiety located at 3'-termini, through the post-synthetic approach and according to the literature [33] . The fluorescence oligonucleotide conjugates (compounds 10 and 11) were obtained ( Fig. 1) and confirmed by MALDI-TOFF mass spectrometry ( Table 1 ). The same protocols were applied for the incorporation of Alexa Fluor 488 at 5'-termini to the rest of modified LOC conjugates (compounds 4 and 5) and unmodified control sequences.
But, in the case of the lipid conjugates (compounds 12 and 13) it was not possible to separate the labelled and unlabelled compounds since according to HPLC analysis, mixtures of starting material and labelled oligonucleotides showed in both cases the same retention time.
Therefore, in order to achieve the fluorescence LOC conjugates modified with lipids at 3'-termini, we decided to incorporate Cy5 dye (Glen Research) into the previously synthesized conjugates (compounds 3-5), through phosphoramidite chemistry approach. After deprotecting and purifying the oligonucleotide conjugates by semi-preparative HPLC, we could obtain the corresponding LOC conjugates labelled with Cy5 (compounds 15-17) at their 5'-termini. Furthermore, we also obtained the unmodified Cy5-labelled oligonucleotide (compound 18) which was used as a control. All conjugates were confirmed by MALDI-TOFF mass spectrometry (Table 1 and Suppl. Figs. S1-S17).
Surface activity of LOCs at air-water and lipid-water interfaces
The Langmuir lipid monolayer technique to mimic half a bilayer may be advantageous because properties such as composition, lateral pressure, surface elasticity and surface density are easily controlled [34, 35] . First, the surface-active properties of LOCs at an air-water interface were analyzed. All
LOCs under study caused a dose-dependent increase in surface pressure at the air-water interface, except the LOC bearing C 12 NH 2 at the 3' termini (compound 1), which did not cause any change in surface pressure (data not shown). ODN itself was not surface-active either. After a certain time, which decreased with increasing LOC concentrations, surface pressure (π) remained constant ( Fig. 2A ). This constant value was operationally defined as an equilibrium value in this context. In order to compare the behaviour of LOCs under the same experimental conditions, π at 4,000 s was chosen as the equilibrium value. As observed in Fig. 2A , the final π (π F ) vs. LOC concentration curves reached a plateau at specific LOC concentration, which was used to test LOC insertion into DOPC monolayers at varying initial π values (Fig. 2B ). All these data indicate that LOCs surface activity at air-water and lipid-water interfaces increased in the following order: ODN-3'-C 12 NH 2 (compound 3) < C 14 -5'-ODN-3'-NH 2 (compound 6) / ODN-3'-C 14 (compound 4) < NH 2 -5'-ODN-3'-C 18 (compound 9) < C 28 -5'-ODN-3'-NH 2 (compound 7). Most importantly, only C 28 -5'-ODN-3'-NH 2 (compound 7) could be inserted into DOPC monolayers at initial lateral pressures above those assumed for cell membranes (around 30 mN/m), implying that this compound should be easily incorporated into the external leaflet of the cell membrane [36, 37] .
Binding of LOCs to lipid bilayer systems
We investigated the spontaneous incorporation of LOCs into membranes bearing a curvature stress and surface charge comparable to those of the plasma membrane surrounding eukaryotic cells by using GUVs and SPBs [38] [39] [40] . These lipid bilayer systems were composed of DiO-or DiD-labelled DOPC/eSM/Chol (2:2:1) in order to analyze the effect of L d and L o lipid phase coexistence on LOC partitioning. All LOCs showed an apparently similar behaviour in both GUV and SPB systems (Suppl. Table S1 ).
Cy5-labelled ODN-C 12 NH 2 (compound 15) showed very weak fluorescence in the L d phase of the GUVs that disappeared with prolonged light excitation (Suppl. Fig. S18 ). Moreover, Cy5-labelled ODN-C 12 NH 2 (compound 15) did not show any binding to SPB under these conditions (Suppl. Fig. S18 ). Large LOC aggregates were visualized in both GUV and SPB experiments. The reactive primary amine at the end of the alkyl chain could be protonated under these experimental conditions (pH 7.4) and bind the negatively charged backbone of the oligonucleotide via electrostatic interactions, leading to LOC aggregates [41, 42] . Indeed in the complexation strategy the formation of ODN-complexes/aggregates is based on the electrostatic interactions between reactive amines of the cationic agents and the negatively charged phosphate backbone of the oligonucleotides [43] [44] [45] .
ODN-3'-C 14 and ODN-3'-C 18 compounds behaved differently when conjugated to Cy5 or Alexa 488
fluorophores. Cy5-labelled C 14 and C 18 containing LOCs (compounds 16 and 17, respectively) were clearly seen in the L d phase of GUVs and SPBs co-localizing with DiO dye (Suppl. Fig. S19 ), but when conjugated to Alexa 488 they did not show any remarkable interaction or insertion into the lipid bilayer, nor did Alexa 488-labelled C 14 -5'-ODN (compound 10) (Suppl. Fig. S20 ). This discrepancy may simply be due to the presence of the linker in combination with the size and hydrophobicity differences between the conjugated fluorophores, which could be incorporated with different efficiencies and/or interfere in the stability and/or properties of LOCs. Indeed, Cy5 is more hydrophobic than Alexa 488. Similarly other authors have reported that uptake of fluorescein-labelled ODN-conjugates could be altered due to the lipophilic nature of this fluorophore [5] . Moreover, since the labelling of these LOCs with Alexa 488 provided a mixture of labelled and unlabelled products that could not be separated by HPLC a 4% (w/v) agarose gel was performed in order to check the state of these LOCs. This assay revealed the poor stability of Alexa 488-labelled ODN-3'-C 18 (compound 13), which was prone to form aggregates, whereas
Alexa 488-labelled ODN-3'-C 14 (compound 12) behaved similarly to the unlabelled or Cy5-labelled compounds (Suppl. Figs. S21 and S22 ).
Essentially, it could be reasonably expected that Alexa 488-labelled C 28 -5'-ODN (compound 11) would also spontaneously incorporate into L o domains since it is long known that dual lipid modification appears to facilitate association with lipid rafts [46] . However, this LOC showed a remarkable and rapid incorporation into both lipid bilayer phases, being equally distributed between L d and L o domains after equilibration (Fig. 3 ). Similar observations have been reported by other authors who used a single cholesterol moiety or two cholesteryl-TEG moieties containing double-stranded DNA structures, which did not exclusively partition into the L o phase [47, 48] . This could be due to the fact that probes designed as cholesterol mimics usually do not satisfactorily reproduce the properties of pure cholesterol [47, 48] .
Alternatively, the presence of two ether bonds in the structure of this LOC could be related to its homogeneous distribution in lipid membrane model systems, since ether-linked glycerophospholipids appear to be more loosely packed in membranes, thereby increasing their fluidity [49, 50] . In contrast, the fact that Alexa 488-labelled C 28 -5'-ODN (compound 11) compound, that possess two neighbouring alkyl chains, could be associated with model membranes is opposite to what it was observed by other authors who reported that a lipid-anchored oligonucleotide with two neighbouring alkyl chains may tend to form stable supramolecular structures in an aqueous environment, making it difficult to insert into preformed membranes [51] . In that case the oligonucleotide was conjugated to a chalcone moiety bearing longer alkyl chains (2 × C 16 ) than those of C 28 -5'-ODN (2 × C 14 ). Our interpretation for this different behaviour relies on the higher hydrophobicity of the chalcone moiety with regard to the lipid anchor used in our work. Moreover, in SPB experiments reproducible, peculiar Alexa 488-enriched rounded structures were observed suggesting that these structures were at least in part formed by this LOC. Importantly, the homogeneous distribution of Alexa 488-labelled C 28 -5'-ODN (compound 11) in liquid domains co-existing in bilayers may provide several advantages in cell systems in terms of alternative internalization routes.
Thus, once this LOC is inserted into the lipid bilayer, it could interact with a number of transmembrane proteins involved in distinct uptake pathways, thereby inducing its internalization through different routes.
Cell cytotoxicity, cellular binding, uptake and localization of LOCs in HeLa cells
The biological relevance of the above data was also studied by examining the uptake and subcellular localization of LOCs in HeLa cells, as this cell line is commonly used to study cell biology of uptake mechanisms [52] [53] [54] [55] . Mycoplasma free HeLa cultures were used in order to avoid Mycoplasma infectioninduced enhanced oligonucleotide uptake (Suppl. Fig. S23 ).
Cell cytotoxicity studies were performed to evaluate the possible toxic effects that these LOCs could trigger on HeLa cells. The data showed that these LOCs were neither cytotoxic nor antiproliferative at 5 µM, except for the LOC bearing a C 28 moiety at the 5'-termini of the ODN, which decreased cell viability by over 30% and 60% during 24 and 48 h of incubation, respectively (Suppl. Fig. S24 ). This undesired result caused by this LOC is probably related to its high and rapid incorporation into membranes as well as to the presence of two ether bonds in this LOC, making it more difficult to degrade [56, 57] .
The observations of binding/uptake experiments carried out with Cy5-labelled LOCs ( (Fig.   4A ). Similar results were observed by Love and co-workers, who reported that an optimized combination of amine group and tail length is necessary to impart delivery activity since not all tested siRNA conjugates carrying a C 12 -amine part moiety but differing in the amine presentation were successful for siRNA silencing, when formulated in combination with other lipids [58] .
In addition to Cy5-labelled compounds, when HeLa cells were incubated with Alexa 488-labelled LOCs (Fig. 4B ), they showed a higher cellular uptake as compared to Alexa 488-labelled control-ODN (compound 14). In this regard, the following internalization behaviour was observed (from the lowest to the highest uptake profile): C 14 -5'-ODN (compound 10) / ODN-3'-C 14 (compound 12) < ODN-3'-C 18 (compound 13) < C 28 -5'-ODN (compound 11) (Fig. 4B) . These results point to a better incorporation when longer and dual alkyl chains are conjugated with the ODN (i.e., higher hydrophobicity). However, the latter observation is not fully in agreement with the results obtained in GUVs and SPBs with the Alexa 488-labelled LOCs bearing C 14 or C 18 moiety at the 3'-or 5'-termini since these LOCs did not show any noticeable incorporation into those membrane systems. Presumably, the experimental conditions chosen in uptake assays could not be ideal since under these conditions (4 h of incubation) precipitation may enhance the association of the LOCs with the cell surface, which could artifactually increase transfection rates of the LOCs that apparently do not insert into model membranes [59] . A further aspect that deserves some comment is that Alexa 488-labelled C 28 -5'-ODN (compound 11)
showed higher internalization efficiency than that of Alexa 488-labelled ODN-lipoplexes (Fig. 4B) . The latter result supports the observations reported by Grijalvo and co-workers, where the siRNA carrying the C 28 moiety at the 5'-end of the passenger strand showed the best inhibitory effects in the absence of the transfecting agent Oligofectamine. Even more, this compound was the less active siRNA conjugate when combined with the transfecting agent [21] . Also, Lindner and co-workers convincingly demonstrated that myristoyl chains seem to play an important role in cationic liposome-mediated ODN delivery, as in a functional assay with ODN dimyristoyl analogs were the best cationic lipids for ODN transfection even in the absence of helper lipids [57] .
Subcellular localization assays revealed that all LOCs, as well as control-ODNs, were visualized in the nucleus of HeLa cells, indicating that these lipid moieties conjugated to ODN do not interfere with the ODN destination (Fig. 5) . Moreover, when the experiments were achieved either in the absence or presence of Transfectin same nuclear localization was observed, suggesting that conjugation and complexation approaches are equaly efficient ( Fig. 5A and 5B).
Regarding cellular uptake and subcellular localization of LOCs, both Cy5-and Alexa 488-labelled LOCs were detected in the nucleus of HeLa cells as control ODNs (Fig. 5C and 5D ).
In particular, the LOC containing a C 28 moiety showed very high fluorescence localized in the nucleus of HeLa cells, with small intense fluorescent spots within it (Fig. 5D) , suggesting that the concentration used (500 nM) in this assay could be saturating due to its high and rapid incorporation into cells.
Strikingly, when a lower concentration of this LOC was tested (50 nM), this compound was still capable of reaching the nucleus even after 30 min incubation, exhibiting a redistribution from the nucleus to the cytoplasmic membrane-bound compartments and membrane-like regions at longer periods of time (4 h) (Suppl. Fig. S25 ) [61] . The latter observation underscores the fact that the C 28 lipid modification seems to be a promising moiety for small nucleic acid-based delivery since it does not interfere with the ODN destination or disrupt RNAi machinery when conjugated to siRNA [21] .
Cell cytotoxicity, cellular binding, uptake and localization of C 28 -5'-ODN in different cell lines
In order to demonstrate whether the results obtained by C 28 -5'-ODN in HeLa cells were more generally applicable, eight more cell lines were examined (PANC-1, C2C12, CHO K1, CHO CR3+, J774A.1 CR3-, J774A.1, RAW 267). This LOC did not show any cytotoxic effect in all cell lines tested during 24 h of incubation (Fig. 6A) . Subsequently, cellular uptake in these cell lines was analyzed. As expected, this LOC was better internalized in all cell lines tested compared to control-ODN ( Despite the universality in membrane traffic, each cell type shows major unique features which obviously may influence intracellular delivery and traffic of the compound to be internalized [63] . Thus, it can be assumed that a particular cell type may select a specific uptake pathway for the internalization of a delivery system leading to an uptake efficiency, which may largely differ from those achieved by other cell types selecting different internalization routes. Related to this assumption, different results have been obtained in the cellular uptake (Fig. 6B ) and subcellular localization (Fig. 7) where C 28 -5'-ODN can be localized mostly in the nucleus of several but not all the cell lines tested under these experimental conditions. HeLa, PANC-1 and C2C12 cells first showed a nuclear LOC localization (30 min) that was further redistributed into the cell cytoplasm after longer time periods (4 h). Likewise, the transport of ODNs first to and then out of the nucleus has already been reported [61] . These observations are also in agreement with the results achieved by other authors who reported that the efficiency of cellular accumulation of lipophilic siRNAs was dependent upon the type of cell line tested [29] .
By contrast, weak fluorescence was observed in the nucleus of U87.CD4.CXCR4, CHO CR3+, J774A.1 and RAW264.7 cell lines, being more noticeable at the cell cytoplasm both at short and long time periods. Finally, CHO K1 and J774A.1 CR3-cell lines showed very weak fluorescence at either 30 min or 4 h incubation times, suggesting an inefficient LOC uptake (Fig. 7) .
Role of CR3 receptor in the enhancement of C 28 -5'-ODN internalization
Related to the results obtained by CR3-presenting cell lines, previous investigations established an important role of these integrins in the enhancement of ODN internalization, thereby promoting a receptormediated endocytosis [62] . Thus, we examined whether this enhanced LOC internalization was mediated by this receptor. First cell surface CR3 expression was analyzed by flow cytometry. It was confirmed that CHO CR3+, J774A.1 and RAW 264.7 expressed CR3 integrin (Suppl. Fig S26) . In this experiment CHO K1 and J774A.1 CR3-cell lines were used as negative controls.
To perform a deeper analysis of the involvement of CR3 integrin in the LOC uptake, soluble fibrinogen, a natural ligand for this integrin, was selected to compete with the LOC for the binding sites of this receptor, thereby blocking LOC internalization, as previously reported by other authors [62, [64] [65] [66] . In this experiment, again CHO K1 and J774A.1 CR3-cell lines were used as negative controls for CR3-mediated LOC internalization, assuming that in these cell lines LOC uptake did not vary in the presence of soluble fibrinogen as observed in Fig. 8A . On the contrary, in the presence of soluble fibrinogen the cellular uptake of this LOC was significantly blocked in CR3 presenting cells (i.e., CHO CR3+, J774A.1
and RAW 264.7 cells). In fact, cellular uptake is inhibited at least up to 30% in the presence of 500 nM soluble fibrinogen. These results suggest the direct involvement of this receptor in LOC internalization (Fig. 8 ).
In conclusion, LOCs presenting longer or double-tailed lipid modifications (i.e., with higher hydrophobicity) showed the best incorporation behaviour into both membrane lipid model and cell Trypan Blue (0.2%, final concentration) was used to quench extracellular fluorescence. Tables   Table 1 MALDI-TOF spectrometry data of the oligonucleotides prepared in this study.
Compound MW (calcd)
